Petros Grivas, Clinical Director of the GU cancers Program at the University of Washington, shared a post by Andrew C. Hsieh, Professor and Associate Director Human Biology Division in the Fred Hutch Cancer Center, on X, adding:
“Congrats Haffner Fred Hutch evaluating intra-patient heterogeneity in prostate cancer so relevant to trial design and clinical applications!’
Quoting Andrew C. Hsieh’s post:
“Go Haffner Lab Fred Hutch, UW Dept. of Laboratory Medicine and Pathology ! Intra pt tumor heterogeneity in prostate cancer, a deep dive.”
Title: Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer
Authors: Martine P. Roudier, Roman Gulati, Erolcan Sayar, Radhika A. Patel, Micah Tratt, Helen M. Richards, Paloma Cejas, Miguel Munoz Gomez, Xintao Qiu, Yingtian Xie, Brian Hanratty, Samir Zaidi, Jimmy L. Zhao, Mohamed Adil, Chitvan Mittal, Yibai Zhao, Ruth Dumpit, Ilsa Coleman, Jin-Yih Low, Thomas Persse, Patricia Galipeau, John K. Lee, Maria Tretiakova, Meagan Chambers, Funda Vakar-Lopez, Lawrence D. True, Marie Perrone, Hung-Ming Lam, Lori A. Kollath, Chien-Kuang Cornelia Ding, Stephanie Harmon, Heather H. Cheng, Evan Y. Yu, Robert B. Montgomery, Jessica E. Hawley, Daniel W. Lin, Eva Corey, Michael T. Schweizer, Manu Setty, Gavin Ha, Charles L. Sawyers, Colm Morrissey, Henry Long, Peter S. Nelson, and Michael C. Haffner
Read the Full Article at The Journal of Clinical Investigation.
More posts featuring Petros Grivas on OncoDaily.